NCT06726382View on ClinicalTrials.gov

KF2024#1-trial: Esketamine Interaction Study

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Drug InteractionsFood-drug Interaction
Interventions
DRUG

Esketamine Nasal Spray

1 x 28 mg dose

DRUG

Esketamine 28 mg

1 x 5,6 ml p.o.

DRUG

Cobicistat 150 MG

1 x 150 mg tablet

Trial Locations (1)

Unknown

Department of Clinical Pharmacology, Helsinki

All Listed Sponsors
collaborator

University of Helsinki

OTHER

lead

Helsinki University Central Hospital

OTHER